Awareness and knowledge regarding cervical cancer and screening practices among women attending a tertiary care center in Bhavnagar, Gujarat: a prospective observational study

Drashti Rathod; Kanaklatta D. Nakum

doi:10.18203/2320-1770.ijrcog20262095

Authors

Drashti Rathod Department of Obstetrics and Gynecology, Sir T. Hospital, Bhavnagar, Gujarat, India
Kanaklatta D. Nakum Department of Obstetrics and Gynecology, Sir T. Hospital, Bhavnagar, Gujarat, India

DOI:

https://doi.org/10.18203/2320-1770.ijrcog20262095

Keywords:

Awareness, Cervical cancer, Pap smear, Screening, Women’s health

Abstract

Background: Cervical cancer remains one of the leading causes of cancer-related mortality among women in developing countries, particularly in India. Despite being preventable through effective screening methods like the Pap smear, lack of awareness leads to late-stage presentation and poor outcomes. Objective was to assess the awareness and knowledge of cervical cancer and its screening methods among women attending a tertiary care center.

Methods: This prospective observational study was conducted among 100 women aged 30-60 years attending Gopinath Maternity Home and Sir T. Hospital, Bhavnagar. From January 2025 to March 2025, data were collected using a structured questionnaire assessing socio-demographic variables and knowledge regarding cervical cancer and screening.

Results: The majority of participants were in the 36-40 years age group and were married. Most women had limited knowledge regarding symptoms, risk factors, and screening methods. Only a small proportion correctly identified Pap smear as a screening tool and understood its significance.

Conclusions: Awareness regarding cervical cancer and its screening remains inadequate. There is a need for targeted educational programs to improve knowledge and promote early detection practices.

References

Ferlay J, Soerjomataram I, Dikshit R, Eser S, Mathers C, Rebelo M, et al. Cancer incidence and mortality worldwide. Int J Cancer. 2015;136:E359-86.

Bray F, Ferlay J, Soerjomataram I, Siegel RL, Torre LA, Jemal A. Global cancer statistics 2018. CA Cancer J Clin. 2018;68:394-424.

ICO Information Centre on HPV and Cancer. Human papillomavirus and related diseases report. Available from: https://hpvcentre.net/statistics/reports/IND.pdf. Accessed on 22 February 2026.

Saslow D, Solomon D, Lawson HW, Killackey M, Kulasingam SL, Cain J, et al. Cervical cancer screening guidelines. CA Cancer J Clin. 2012;62:147-72.

Bal MS, Goyal R, Suri AK, Mohi MK. Detection of abnormal cervical cytology. J Cytol. 2012;29:45-7.

Patel MM, Pandya AN, Modi J. Pap smear study in cancer screening. Nat J Community Med. 2011;2:49-51.

Gupta K, Malik NP, Sharma VK, Verma N, Gupta A, Sharma R, et al. Prevalence of cervical dysplasia. J Cytol. 2013;30:257-62.

Ansari M, Mehdi G, Arif SH, Ansari H, Khan T, Smail M, et al. Cervical epithelial lesions study. Diagn Cytopathol. 2012;40:976-83.

Sankaranarayanan R, Nene BM, Shastri SS, Jayant K, Muwonge R, Budukh AM, et al. HPV screening in India. N Engl J Med. 2009;360:1385-94.

Arbyn M, Weiderpass E, Bruni L, de Sanjosé S, Saraiya M, Ferlay J, et al. Estimates of incidence and mortality. Lancet Glob Health. 2020;8:e191-203.

World Health Organization. Cervical cancer. Geneva: World Health Organization; 2024.

Sung H, Ferlay J, Siegel RL, Laversanne M, Soerjomataram I, Jemal A, et al. Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2021;71(3):209-49.

Bruni L, Albero G, Serrano B, Mena M, Gómez D, Muñoz J, et al. Human papillomavirus and related diseases in India. ICO/IARC Information Centre on HPV and Cancer; 2023.

Basu P, Mittal S, Banerjee D, Singh P, Panda C, Dutta S, et al. Diagnostic accuracy of VIA and cytology in cervical cancer screening among Indian women. Int J Cancer. 2019;145(5):1273-81.

Bhatla N, Aoki D, Sharma DN, Sankaranarayanan R. Cancer of the cervix uteri: 2021 update. Int J Gynecol Obstet. 2021;155(Suppl 1):28-44.

Arbyn M, Smith SB, Temin S, Sultana F, Castle P. Detecting cervical precancer and reaching underscreened women by using HPV testing on self-samples: updated meta-analyses. BMJ. 2018;363:k4823.

Gupta S, Palmer C, Bik EM, Cardenas JP, Nuñez H, Kraal L, et al. Self-sampling for HPV testing: increased cervical cancer screening participation and incorporation in international screening programs. Front Public Health. 2018;6:77.

Mishra GA, Pimple SA, Shastri SS. Prevention of cervical cancer in India. Oncology. 2016;91(Suppl 1):1-7.

Singh E, Seth S, Rani V, Srivastava DK. Awareness of cervical cancer screening among women in a rural population of India. Int J Community Med Public Health. 2017;4(6):2003-7.

Dhendup T, Tshering P. Cervical cancer knowledge and screening behaviors among female university graduates of Bhutan. BMC Womens Health. 2014;14:44.

Gakidou E, Nordhagen S, Obermeyer Z. Coverage of cervical cancer screening in 57 countries: low average levels and large inequalities. PLoS Med. 2008;5(6):e132.

Perkins RB, Guido RS, Castle PE, Chelmow D, Einstein MH, Garcia F, et al. 2019 ASCCP risk-based management consensus guidelines. J Low Genit Tract Dis. 2020;24(2):102-31.

Canfell K, Kim JJ, Brisson M, Keane A, Simms KT, Caruana M, et al. Mortality impact of achieving WHO cervical cancer elimination targets. Lancet. 2020;395(10224):591-603.

Schiffman M, Castle PE, Jeronimo J, Rodriguez AC, Wacholder S. Human papillomavirus and cervical cancer. Lancet. 2007;370(9590):890-907.

Denny L, Herrero R, Levin C, Kim JJ. Cervical cancer. In: Disease Control Priorities. 3rd ed. Washington (DC): World Bank; 2015:69-84.